GLP-1 receptor agonists provide important cardiometabolic benefits, particularly for weight management, glycemic control, renal protection, and reduction of atherosclerotic cardiovascular risk, although their direct effects in established heart failure remain less certain
Georgina Glenn July 23rd 2026 Georgina Glenn July 2nd 2026 Georgina Glenn June 18th 2026
For weight loss drugs specifically, he argues prior authorization is essential, and while he doesnt always recommend imposing a hard maximum on weight loss coverage, that kind of cap can help contain spending
The concept of microdosing isnt new
It may be used in controlled research settings for comparative evaluation of receptor activity, ligand-receptor interaction, and related analytical studies